Published in J Leukoc Biol on July 31, 2014
Antimicrobial peptides in 2014. Pharmaceuticals (Basel) (2015) 1.30
Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing? Front Immunol (2016) 0.84
Cathelicidin impact on inflammatory cells. Cent Eur J Immunol (2015) 0.79
Neutrophil Extracellular Traps Go Viral. Front Immunol (2016) 0.77
Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and Structural Analysis. PLoS One (2015) 0.76
Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview. Front Immunol (2017) 0.75
The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory Therapy. Pharmaceuticals (Basel) (2016) 0.75
Neutrophil extracellular traps kill bacteria. Science (2004) 23.64
Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med (2011) 5.60
PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med (2010) 4.74
Alarmins: chemotactic activators of immune responses. Curr Opin Immunol (2005) 3.57
A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J Immunol (2010) 3.20
Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol (2011) 2.57
The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol (2002) 2.57
Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. Cell Host Microbe (2012) 2.48
A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell (2013) 2.38
Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J Immunol (2009) 2.28
Retracted CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation. Nat Med (2010) 2.17
The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol (2003) 2.15
Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J Clin Invest (1994) 2.14
Innate immune collectin surfactant protein D simultaneously binds both neutrophil extracellular traps and carbohydrate ligands and promotes bacterial trapping. J Immunol (2011) 1.89
Effects of influenza A virus on human neutrophil calcium metabolism. J Immunol (1988) 1.68
Human defensins and LL-37 in mucosal immunity. J Leukoc Biol (2009) 1.67
NET balancing: a problem in inflammatory lung diseases. Front Immunol (2013) 1.61
The role of neutrophils during mild and severe influenza virus infections of mice. PLoS One (2011) 1.61
An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J Immunol (2006) 1.55
The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice. Respir Res (2008) 1.46
Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J Immunol (2012) 1.44
Vitamin D and the anti-viral state. J Clin Virol (2011) 1.40
Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One (2011) 1.39
PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS One (2011) 1.39
Intracellular receptor for human host defense peptide LL-37 in monocytes. J Immunol (2009) 1.38
Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways. J Immunol (2007) 1.37
Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses. J Immunol (2007) 1.30
Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J Cyst Fibros (2004) 1.29
CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Am J Respir Crit Care Med (2012) 1.28
Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D. J Immunol (2009) 1.22
LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature. J Immunol (2010) 1.20
Neutrophils sustain effective CD8(+) T-cell responses in the respiratory tract following influenza infection. Immunol Cell Biol (2011) 1.15
Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils. Eur J Immunol (2009) 1.14
Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs. J Immunol (2009) 1.13
Host defense peptide LL-37 selectively reduces proinflammatory macrophage responses. J Immunol (2011) 1.12
Characterization of influenza A virus activation of the human neutrophil. Blood (1990) 1.07
Neutrophil survival is markedly reduced by incubation with influenza virus and Streptococcus pneumoniae: role of respiratory burst. J Leukoc Biol (2001) 1.05
The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii. Peptides (2013) 1.04
Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(+) T cells. PLoS One (2012) 1.01
The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. J Gen Virol (2012) 0.98
Leukotriene B4 induces release of antimicrobial peptides in lungs of virally infected mice. J Immunol (2008) 0.96
The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium. Am J Respir Cell Mol Biol (2010) 0.93
Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages. J Leukoc Biol (2009) 0.93
Cationic host defence peptides: potential as antiviral therapeutics. BioDrugs (2013) 0.92
The amazing innate immune response to influenza A virus infection. Innate Immun (2013) 0.91
Neutrophil extracellular traps (NETs) and infection-related vascular dysfunction. Blood Rev (2012) 0.89
The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus. PLoS One (2013) 0.88
Cathelicidin LL-37 in bronchoalveolar lavage and epithelial lining fluids from COPD patients and healthy individuals. J Biol Regul Homeost Agents (2012) 0.83